Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate (Ritalin)-associated cataract and glaucoma.

Chao-Kung Lu1, Tung-Mei Kuang, Joe Ching-Kuang Chou

  • 1Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.

Journal of the Chinese Medical Association : JCMA
|December 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of preservative-free versus preserved timolol eye drops in glaucoma: A randomized crossover study.

Journal of the Chinese Medical Association : JCMA·2026
Same author

Acute Necrotizing Retinopathy After Xen Gel Stent Implantation.

Journal of glaucoma·2023
Same author

Bleb-related infection after primary trabeculectomy: medical chart reviews from 1993 to 2021.

The British journal of ophthalmology·2022
Same author

Pseudophakic pupillary block after phacoemulsification and posterior chamber intraocular lens implantation: Cause identification and treatment refinement.

Photodiagnosis and photodynamic therapy·2022
Same author

Changes in intraocular pressure after pharmacological pupil dilatation in an elderly Chinese population in Taiwan: The Shihpai eye study.

Journal of the Chinese Medical Association : JCMA·2022
Same author

Association of Primary Open-angle Glaucoma With Tinnitus: A Nationwide Population-Based Study.

Journal of glaucoma·2022

High-dose methylphenidate (Ritalin) may cause cataracts and glaucoma in children with ADHD. This case highlights potential serious ocular side effects requiring medical awareness.

Area of Science:

  • Ophthalmology
  • Pediatric Neurology
  • Pharmacology

Background:

  • Methylphenidate hydrochloride (Ritalin) is a primary treatment for Attention Deficit Hyperactivity Disorder (ADHD).
  • Previous reports suggest a potential link between methylphenidate and glaucoma.

Observation:

  • A 10-year-old boy with ADHD on long-term, high-dose methylphenidate presented with blurred vision.
  • Ocular examination revealed elevated intraocular pressure (IOP), posterior subcapsular cataracts, optic disc cupping, and visual field constriction.

Findings:

  • The patient developed both cataract and glaucoma, which were resistant to medical management.
  • Surgical intervention (cataract and glaucoma surgery) led to improved visual acuity and normalized IOP.

Implications:

Related Experiment Videos

  • This case suggests that high-dose methylphenidate may induce or exacerbate cataract and glaucoma.
  • Clinicians should monitor for ocular side effects in pediatric patients receiving methylphenidate.
  • Further research is needed to elucidate the mechanism of methylphenidate-induced ocular toxicity.